Details for Patent: 8,722,085
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,722,085 protect, and when does it expire?
Patent 8,722,085 protects CONTRAVE and is included in one NDA.
This patent has nineteen patent family members in thirteen countries.
Summary for Patent: 8,722,085
Title: | Methods for administering weight loss medications |
Abstract: | Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications. |
Inventor(s): | McKinney; Anthony (San Diego, CA), Tollefson; Gary (Indianapolis, IN), Weber; Eckard (San Diego, CA), Soltero; Rick (Holly Springs, NC) |
Assignee: | Orexigen Therapeutics, Inc. (La Jolla, CA) |
Application Number: | 12/838,364 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,722,085 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
Drugs Protected by US Patent 8,722,085
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,722,085
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 063958 | See Plans and Pricing | |||
Australia | 2007319472 | See Plans and Pricing | |||
Canada | 2668885 | See Plans and Pricing | |||
Chile | 2007003246 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |